HomeMedicines › Cifotrex Syrup

Cifotrex Syrup

Cefixime (50mg)

MRP (typical)
₹59.07 – ₹79.92
GST rate
5.0%
HSN
3004
Schedule
General
Pack
bottle of 15 ml Syrup
Manufacturer
Biocare Remedies

About Cifotrex Syrup

Cifotrex Syrup contains Cefixime 50mg, which belongs to the third-generation cephalosporin class of antibiotics. Cefixime is commonly available in various strengths including 50mg, 100mg, and 200mg formulations across tablets, capsules, and oral suspension forms. This medication falls under GST rate of 5% in India with HSN code 3004, applicable to pharmaceutical preparations for therapeutic use.

Substitutes and alternatives

The following medicines contain the same active ingredient (Cefixime (50mg)) and may be offered by pharmacists as substitutes. Actual substitute selection depends on availability at your pharmacy and prescribing doctor's instructions.

Moxinow Tablet SR
MRP ₹270.3
Cefix 200 Tablet
MRP ₹119.39

Frequently asked

What is the GST rate and HSN code for Cifotrex Syrup?

Cifotrex Syrup attracts 5% GST in India under HSN code 3004, which covers medicaments consisting of mixed or unmixed products for therapeutic purposes.

What schedule classification does this medicine fall under?

Cifotrex Syrup is classified as a General schedule medicine, meaning it can be sold without requiring a prescription from registered medical practitioners.

What are some common brand variants of Cefixime 50mg syrup available in India?

Common Cefixime 50mg syrup brands in the Indian market may include Cefitas, Mahacef, Cefolac, Taxim-O, and Ixime, among others from various pharmaceutical manufacturers.

Selling Cifotrex Syrup at your pharmacy?

Nesayo tracks your stock, flags near-expiry, and auto-orders from your distributor when you run low.

Start free →

This page is informational only. Pricing and availability vary by pharmacy, location, and time. Verify current MRP on the printed package before sale. Consult a registered physician or pharmacist for medical advice. Nesayo is not a medical device and does not provide clinical decision support.